Market Overview:
The global Helicobacter pylori diagnostics market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of H. pylori infection, rising demand for point-of-care (POC) tests, and technological advancements in Helicobacter pylori diagnostics. Based on type, the global Helicobacter pylori diagnostics market can be segmented into invasive techniques, non-invasive techniques, and Helicobacter Pylori diagnostic. The invasive techniques segment is expected to account for the largest share of the global market in 2018 owing to its high accuracy rate and ability to detect all strains of H. pylori bacteria present in a patient’s stomach lining tissue sample. Based on application, the hospitals and clinics segment is expected to account for the largest share of the global market in 2018 owing its widespread use among patients with suspected or confirmed cases of H.
Product Definition:
Helicobacter pylori diagnostics is the process of identifying and confirming the presence of Helicobacter pylori bacteria in a patient. This is an important test, as H. pylori infection can cause a number of health problems, including ulcers and stomach cancer.
Invasive Techniques:
Invasive techniques are used to obtain a sample of the inside of the body. It is done by using a device called as an endoscope. The endoscope has thin, hollow tubes and it can be inserted into the body through the mouth, nose or even anus.
Non-invasive Techniques:
Non-invasive techniques are the procedures that do not involve any cutting of the skin. Some of these procedures include urography, chromopertubation, gastric emptying studies, and radiography. The major advantage associated with these tests is that they cause less pain to the patient as well as lesser damage to the stomach lining than invasive methods (cutting open the stomach).
The increasing prevalence of H.
Application Insights:
Based on application, the global market is segmented into hospitals and clinics, diagnostic laboratories and other settings. Hospitals and clinics were estimated to be the largest segment in 2017 owing to rising awareness about H. pylori infection among patients with gastric ulcers at hospitals or medical centers. In addition, a rise in number of hospital admissions for peptic ulcer disease also boosts the demand for diagnosis of Helicobacter pylori infection during treatment planning at these healthcare facilities.
The diagnostic laboratory was estimated to be one of the fastest-growing segments due largely to an increase in number of commercial laboratories that offer Helicobacter pylori testing services as part as their regular panel of blood tests offered to patients seeking medical care at these facilities.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of gastric cancer and ulcers, rising adoption of technologically advanced products, and presence of well-established healthcare facilities. In addition, high cost associated with diagnostic procedures in this region is also one factor responsible for regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure & availability; growing awareness about early diagnosis; increase in government initiatives for mass medication againstHelicobacter Pylori infection; and rise in medical tourism activities supported by low cost treatment offered by various countries such as India & China.
Growth Factors:
- Increasing incidence of Helicobacter pylori infection: The global incidence of Helicobacter pylori infection is high and is estimated to be around 50%. This number is expected to grow in the coming years due to the increasing population and changing lifestyle habits. This will create a large pool of patients who will require diagnosis and treatment for H. pylori infection, thereby driving the growth of the Helicobacter Pylori Diagnostics market.
- Rising demand for point-of-care diagnostics: The demand for point-of-care diagnostics is rising as they are convenient, fast, and easy to use. They also provide results in a short time frame, which is ideal for urgent cases. This growing demand will drive the growth of the Helicobacter Pylori Diagnostics market as it offers similar benefits.
- Technological advancements: The field of diagnostics is constantly evolving with new technologies being developed every day. These technologies are being used in novel ways to improve accuracy and speed up diagnosis times, making them more accessible to patients worldwide. This trend will continue in the future, propelling the growth ofthe Helicobacter Pylori Diagnostics market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Helicobacter Pylori Diagnostics Market Research Report
By Type
Invasive Techniques, Non-invasive Techniques, Helicobacter Pylori Diagnostic
By Application
Hospitals and Clinics, Diagnostic Laboratories
By Companies
Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Halyard Health, Cardinal Health, Beckman Coulter, Agilent Technologies, Coris BioConcept, Helicobacter Pylori Diagnostic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Helicobacter Pylori Diagnostics Market Report Segments:
The global Helicobacter Pylori Diagnostics market is segmented on the basis of:
Types
Invasive Techniques, Non-invasive Techniques, Helicobacter Pylori Diagnostic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Diagnostic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sekisui Diagnostics
- F. Hoffmann-La Roche
- Medline Industries
- Meridian Bioscience
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Alpha Laboratories
- EKF Diagnostics
- Quidel
- Halyard Health
- Cardinal Health
- Beckman Coulter
- Agilent Technologies
- Coris BioConcept
- Helicobacter Pylori Diagnostic
Highlights of The Helicobacter Pylori Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Invasive Techniques
- Non-invasive Techniques
- Helicobacter Pylori Diagnostic
- By Application:
- Hospitals and Clinics
- Diagnostic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Helicobacter Pylori Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Helicobacter Pylori (H. pylori) is a bacterium that can cause gastritis, peptic ulcers, and other stomach problems. Tests are available to diagnose H. pylori infection and to monitor the progress of treatment.
Some of the major companies in the helicobacter pylori diagnostics market are Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Halyard Health, Cardinal Health, Beckman Coulter, Agilent Technologies, Coris BioConcept, Helicobacter Pylori Diagnostic.
The helicobacter pylori diagnostics market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Helicobacter Pylori Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Helicobacter Pylori Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Helicobacter Pylori Diagnostics Market - Supply Chain
4.5. Global Helicobacter Pylori Diagnostics Market Forecast
4.5.1. Helicobacter Pylori Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Helicobacter Pylori Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Helicobacter Pylori Diagnostics Market Absolute $ Opportunity
5. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Type
5.3.1. Invasive Techniques
5.3.2. Non-invasive Techniques
5.3.3. Helicobacter Pylori Diagnostic
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Diagnostic Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
9. North America Helicobacter Pylori Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Diagnostic Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Type
9.7.1. Invasive Techniques
9.7.2. Non-invasive Techniques
9.7.3. Helicobacter Pylori Diagnostic
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
10. Latin America Helicobacter Pylori Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Diagnostic Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Type
10.7.1. Invasive Techniques
10.7.2. Non-invasive Techniques
10.7.3. Helicobacter Pylori Diagnostic
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
11. Europe Helicobacter Pylori Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Diagnostic Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Type
11.7.1. Invasive Techniques
11.7.2. Non-invasive Techniques
11.7.3. Helicobacter Pylori Diagnostic
11.8. Bais Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Helicobacter Pylori Diagnostics Demand Share, 2019-2026
12. Asia Pacific Helicobacter Pylori Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Diagnostic Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Type
12.7.1. Invasive Techniques
12.7.2. Non-invasive Techniques
12.7.3. Helicobacter Pylori Diagnostic
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Helicobacter Pylori Diagnostics Demand Share, 2019-2026
13. Middle East & Africa Helicobacter Pylori Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Diagnostic Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Type
13.7.1. Invasive Techniques
13.7.2. Non-invasive Techniques
13.7.3. Helicobacter Pylori Diagnostic
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Helicobacter Pylori Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Helicobacter Pylori Diagnostics Market: Market Share Analysis
14.2. Helicobacter Pylori Diagnostics Distributors and Customers
14.3. Helicobacter Pylori Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sekisui Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. F. Hoffmann-La Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medline Industries
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Meridian Bioscience
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Thermo Fisher Scientific
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alpha Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. EKF Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Quidel
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Halyard Health
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cardinal Health
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Beckman Coulter
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Agilent Technologies
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Coris BioConcept
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Helicobacter Pylori Diagnostic
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
